載脂蛋白C3(APOC3)重組蛋白
Recombinant Apolipoprotein C3 (APOC3)
Apo-C3; APOCIII; APOC-III
- 編號RPB890Mu01
- 物種Mus musculus (Mouse,小鼠) 相同的名稱,不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU per 1μg (determined by the LAL method).
- 亞細胞定位分泌
- 預測分子量10.4kDa
- 實際分子量21kDa(差異分析請參閱說明書)
- 片段與標簽Glu21~Ser99 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl, pH8.0, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點5.1
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1080 ¥ 2700 ¥ 5400 ¥ 16200 ¥ 40500
- 欲了解實際交易價格和更多情況,請與當?shù)亟涗N商聯(lián)系!
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當?shù)臈l件下存儲,損失率低于5%。
增值服務
相關產品
編號 | 適用物種:Mus musculus (Mouse,小鼠) | 應用(僅供研究使用,不用于臨床診斷!) |
APB890Mu01 | 載脂蛋白C3(APOC3)活性蛋白 | Cell?culture;?Activity?Assays. |
RPB890Mu01 | 載脂蛋白C3(APOC3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB890Mu02 | 載脂蛋白C3(APOC3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB890Mu02 | 載脂蛋白C3(APOC3)多克隆抗體 | WB; IHC; ICC; IP. |
PAB890Mu01 | 載脂蛋白C3(APOC3)多克隆抗體 | WB; IHC; ICC; IP. |
MAB890Mu21 | 載脂蛋白C3(APOC3)單克隆抗體 | WB; IHC; ICC; IP. |
SEB890Mu | 載脂蛋白C3(APOC3)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB890Mu | 載脂蛋白C3(APOC3)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSB890Mu01 | 載脂蛋白C3(APOC3)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Atherosclerosis | Up-reCavia (Guinea pig )lation of Hnf1α gene expression in the liver of rats with experimentally induced chronic renal failure – A possible link between circulating PCSK9 and triacylglycerol concentrations [Pubmed:26978583] |
The Journal of Lipid Research | Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism [Pubmed:27040449] |
Journal of Chromatography A | Application of a new procedure for liquid chromatography/mass spectrometry profiling of plasma amino acid-related metabolites and untargeted shotgun proteomics to identify mechanisms and biomarkers of calcific aortic stenosis [S0021967317311858] |
J Transl Med | Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans [33407555] |
留言咨詢